Archive | Infectious Diseases

Operation ASHA - Fighting Tuberculosis Worldwide

Using Technology and Community Empowerment to Treat Tuberculosis.

TB is has been declared a health emergency by WHO. Over 9 million people are newly infected with TB and 1.4 million die annually. Incomplete TB treatment has led to an alarming rise in DR-TB (Drug Resistant TB), a man-made epidemic. MDR-TB (Multi Drug-Resistant TB), if not fully treated, leads to the dreaded XDR-TB (Extremely […]

Continue Reading
 

Population attributable estimates and Risk factors for Hepatitis.

Estimation of population attributable risks indicates the potential for prevention of hepatitis if the exposure to certain modifiable factors could be eliminated. We estimated the population attributable risks and performed systemetic review of various risk factors for transmission of HBV and HCV ( in 2012)using data from a large nationally representative survey conducted in 2007 […]

Continue Reading
 

Public Responsibility in Research and Development Partnerships

A fatal imbalance exists in the investment in new drugs for neglected diseases, such as sleeping sickness and leishmaniasis, versus diseases prevalent in wealthy countries. From 1975 to 2004, of the 1,556 new drugs marketed only 21 just over one percent were for infectious tropical diseases and tuberculosis, in spite of the huge need.

Continue Reading
 

Improving Home-Based Use of Coartem for Malaria Management in Children Under Five Years of Age

Malaria is the largest cause of health service attendance, hospital admissions and child deaths in Nigeria. Resistances of plasmodium falciparum to chloroquine and sulphadoxine plus pyrimetamine have led to adoption of policy to use Coartem as the first-line drug of treatment.

Continue Reading